GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shengda Bio-Pharm Co Ltd (SHSE:603079) » Definitions » 3-Year EPS without NRI Growth Rate

Zhejiang Shengda Bio-Pharm Co (SHSE:603079) 3-Year EPS without NRI Growth Rate : -7.20% (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Shengda Bio-Pharm Co 3-Year EPS without NRI Growth Rate?

Zhejiang Shengda Bio-Pharm Co's EPS without NRI for the three months ended in Mar. 2025 was ¥0.15.

During the past 12 months, Zhejiang Shengda Bio-Pharm Co's average EPS without NRI Growth Rate was 2035.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was -7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Zhejiang Shengda Bio-Pharm Co was 36.30% per year. The lowest was -39.00% per year. And the median was -2.50% per year.


Competitive Comparison of Zhejiang Shengda Bio-Pharm Co's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Shengda Bio-Pharm Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Shengda Bio-Pharm Co's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Shengda Bio-Pharm Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Zhejiang Shengda Bio-Pharm Co's 3-Year EPS without NRI Growth Rate falls into.


;
;

Zhejiang Shengda Bio-Pharm Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Zhejiang Shengda Bio-Pharm Co  (SHSE:603079) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Zhejiang Shengda Bio-Pharm Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Zhejiang Shengda Bio-Pharm Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Shengda Bio-Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
No.789, Renmin East Road, Chicheng Street, Tiantai County, Zhejiang Province, Hangzhou, CHN, 317200
Zhejiang Shengda Bio-Pharm Co Ltd is a pharmaceutical company. It is mainly engaged in the research and development, and production of biotin and biological preservatives. Its product portfolio includes biotin, folic acid and other vitamin products, as well as nisin and natamycin.
Executives
Pang Ai Ming Director
Zhu Yong Gang Director

Zhejiang Shengda Bio-Pharm Co Headlines

No Headlines